CytoSorbents Corporation (CTSO)

[cars100cars]

Pears, Car-T can cause a short-term inflammation crisis after treatment begins. There is a critical window of perhaps 5 days when CytoSorb could be appropriate to quell a developing cytokine storm. As you know, Car-T reprograms the immune system, and sometimes the immune system restarts in overdrive. It can take a few days for this explosive response to calm down. CytoSorb can help during this window. I recall several CytoSorb notes in which it was discussed that CytoSorb can help to refocus and regulate an immune system that appears to be out of control. By the way, you might want to put NVS on a watchlist. It is up another 60 cents premarket today since an FDA committee recommended 10-0 last Thursday that the FDA adopt its Car-T treatment. KITE and JUNO could ride on this news, too. You might recall that both KITE and JUNO had deaths in their original FDA trials on their Car-T treatments, but have since recovered from those situations. Nobody discussed excessive inflammation, but it was likely part of those fatalities. Also, there are a number of small gene reprogramming companies and gene testing/analysis companies that could benefit as this kind of genomic treatment technique spreads, which is highly likely, given its effectiveness to completely eradicate tumors. Imagine, being cancer free in 30 days after living with tumors for a long period and having gone through chemo or radiation. IMHO, Car-T treatments will take hold, and perhaps be safer with CytoSorb to support recovery. It all makes sense.